Psychiatric Disease

Serious psychiatric disorders are the leading cause of disability worldwide. However, research on these devastating diseases was long stalled because knowledge of their biological underpinnings remained elusive. Founded in 2007, the mission of the Stanley Center for Psychiatric Research is to bring modern genomics to bear on psychiatric diseases and ease the burden for patients and their families.

Since its inception, the Stanley Center has helped reinvigorate the field of psychiatric disease research. Working with a global network of collaborators, Stanley Center researchers seek to construct the genetic architecture of major psychiatric diseases such as schizophrenia, bipolar disorder, and autism. Already, they have assembled the world’s largest collection of DNA samples of psychiatric disease, and have developed cutting-edge tools and methods to analyze research findings. Ultimately, these discoveries will lead to an era of rational and effective treatments for patients coping with these devastating disorders.

We are seeking philanthropic partners in the following projects:

  • Defining the genetic factors that contribute to psychiatric diseases including schizophrenia, bipolar disorder, and autism.

  • Elucidating the biological effects of the genes and variants that have been discovered.

  • Developing the molecular tools to identify pathways and networks in human neural cell types.

  • Identifying the most promising therapeutic targets.

  • Applying genetic discoveries to better predict risk in human populations.

News coverage on our research in psychiatric disease